Papers
2
Total Citations
8
H-Index
2
About
Paolo Silimbani is a leading researcher in pharmaceutical technology and oncology drug compounding, with a focus on the stability, safety, and automation of intravenous chemotherapeutic preparations. His work addresses critical challenges in hospital pharmacy practice, particularly the aseptic preparation of cytotoxic drugs. Silimbani’s most cited study, "Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags" (2020, 6 citations), provides essential stability data that enables the safe, pre-emptive preparation of this vital chemotherapy agent, reducing the need for extemporaneous compounding and improving patient safety. Additionally, his research on "Optimisation of compounding organisation after implementing a robotic system for automated preparation of oncologic drugs" (2019, 2 citations) evaluates the impact of the APOTECAchemo robotic system, demonstrating how automation enhances efficiency, accuracy, and sterility in centralized pharmacy units. Through these contributions, Silimbani has advanced the field of pharmaceutical compounding, offering evidence-based solutions that streamline workflows and minimize risks in oncology care. His work is instrumental for pharmacists and researchers seeking to optimize drug preparation protocols and integrate innovative technologies into clinical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2